Indexing pharmacogenetic knowledge on the World Wide Web

被引:16
作者
Altman, RB [1 ]
Flockhart, DA
Sherry, ST
Oliver, DE
Rubin, DL
Klein, TE
机构
[1] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
[2] Indiana Univ, Div Clin Pharmacol, Indianapolis, IN 46204 USA
[3] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA
来源
PHARMACOGENETICS | 2003年 / 13卷 / 01期
关键词
D O I
10.1097/00008571-200301000-00002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:3 / 5
页数:3
相关论文
共 8 条
[1]   Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency [J].
Andersen, JB ;
Szumlanski, C ;
Weinshilboum, RM ;
Schmiegelow, K .
ACTA PAEDIATRICA, 1998, 87 (01) :108-111
[2]   GenBank [J].
Benson, DA ;
Karsch-Mizrachi, I ;
Lipman, DJ ;
Ostell, J ;
Rapp, BA ;
Wheeler, DL .
NUCLEIC ACIDS RESEARCH, 2002, 30 (01) :17-20
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]   Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer [J].
Furuta, T ;
Ohashi, K ;
Kamata, T ;
Takashima, M ;
Kosuge, K ;
Kawasaki, T ;
Hanai, H ;
Kubota, T ;
Ishizaki, T ;
Kaneko, E .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (12) :1027-1030
[5]   Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders [J].
Hamosh, A ;
Scott, AF ;
Amberger, J ;
Bocchini, C ;
Valle, D ;
McKusick, VA .
NUCLEIC ACIDS RESEARCH, 2002, 30 (01) :52-55
[6]   The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine [J].
Lötsch, J ;
Skarke, C ;
Grösch, S ;
Darimont, J ;
Schmidt, H ;
Geisslinger, G .
PHARMACOGENETICS, 2002, 12 (01) :3-9
[7]  
Stamer UM, 2002, CLIN CHEM, V48, P1412
[8]   Pharmacogenetics of warfarin elimination and its clinical implications [J].
Takahashi, H ;
Echizen, H .
CLINICAL PHARMACOKINETICS, 2001, 40 (08) :587-603